Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Open in API
Filings indexed 410 across all filing types
Latest filing 2013-10-22 Interim / Quarterly Rep…
Country SE Sweden
Listing ST PROB

About Probi

https://www.probi.com/

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is titled 'PROBI AB DELÅRSRAPPORT 2013-01-01 – 2013-09-30', which translates to 'Interim Report'. It contains detailed financial statements, including income statements, cash flow data, segment reporting, and management commentary for the period ending September 30, 2013. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2013
2013-10-22 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is titled 'PROBI AB INTERIM REPORT 1 January 2013 – 30 September 2013'. It contains detailed financial statements, including net sales, operating profit, cash flow, and segment information for the third quarter and the first nine months of 2013. It provides a comprehensive analysis of business performance, significant events, and management commentary. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2013
2013-10-22 English
Probi extends the collaboration with Health World Australia by the launch of Probi Defendum®
Regulatory Filings Classification · 1% confidence The document is a short press release announcing an extension of a distribution agreement and the upcoming launch of a new product (Probi Defendum®) by a partner in Q1 2014. It contains key business updates, financial context (mentioning 2012 income), and contact information, typical of an immediate corporate disclosure. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific regulatory filing like DIRS or DIV, and it is a general business announcement, it best fits the 'Regulatory Filings' (RNS) category as a general, non-specific regulatory disclosure, or potentially an Earnings Release (ER) if it were tied to a reporting period, but here it is a commercial update. Given the nature of immediate, non-periodic business news disclosure, RNS is the most appropriate fallback, although it shares characteristics with an ER in terms of immediacy. However, since it is not explicitly reporting financial results (just mentioning past income), RNS is safer than ER. The length (under 3000 chars) also suggests it is not a comprehensive report.
2013-09-30 English
Probi utökar samarbetet med Health World Australia genom lansering av Probi Defendum®
Regulatory Filings Classification · 1% confidence The document is a 'PRESSMEDDELANDE' (Press Release) announcing a business development: Probi is expanding its collaboration with Health World Australia to launch a new product, Probi Defendum®. It details the expansion, the product, and includes quotes from management. This is a general corporate announcement regarding business operations and partnerships, not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general announcement that doesn't fit the highly specific categories (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory/corporate announcement fallback category, RNS (Regulatory Filings), as it is a public disclosure of material information.
2013-09-30 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification Classification · 1% confidence The document explicitly details changes in shareholding percentages and the number of shares held by a specific holder (Symrise AG) in an issuer (PROBI Aktiebolag). Key phrases like 'Reason for major shareholding notification Buy', 'Resulting distribution of total holdings', and the reporting of voting rights percentages strongly indicate a notification regarding a significant change in ownership. This aligns directly with the definition of Major Shareholding Notification (MRQ). The document is short and contains the core data, not an announcement about a report.
2013-09-03 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for Probi AB covering the period 2013-01-01 to 2013-06-30. It contains detailed financial statements, including income statements, cash flow analysis, segment reporting, and management commentary on business performance. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2013
2013-08-20 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.